• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current methods for the reduction of blood-borne pathogens: a comprehensive literature review.

作者信息

Picker Susanne M

出版信息

Blood Transfus. 2013 Jul;11(3):343-8. doi: 10.2450/2013.0218-12. Epub 2013 Mar 14.

DOI:10.2450/2013.0218-12
PMID:23522896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3729123/
Abstract
摘要

相似文献

1
Current methods for the reduction of blood-borne pathogens: a comprehensive literature review.当前减少血源性病原体的方法：一项全面的文献综述。
Blood Transfus. 2013 Jul;11(3):343-8. doi: 10.2450/2013.0218-12. Epub 2013 Mar 14.
2
Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002).迈向血液供应的普遍病原体灭活（会议报告，第3002页）
Transfusion. 2019 Sep;59(9):3026-3028. doi: 10.1111/trf.15410. Epub 2019 Jun 19.
3
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).美国食品药品监督管理局2018年血液安全病原体减少技术公开研讨会会议记录（评论，第3026页）
Transfusion. 2019 Sep;59(9):3002-3025. doi: 10.1111/trf.15344. Epub 2019 May 29.
4
The usefulness of pathogen inactivation during an outbreak of the new strain of influenza (H1N1).新型甲型H1N1流感病毒疫情期间病原体灭活的效用。
Transfus Med Rev. 2010 Apr;24(2):151-2. doi: 10.1016/j.tmrv.2009.12.001.
5
Transfusion medicine. Second of two parts--blood conservation.输血医学。两部分中的第二部分——血液保护。
N Engl J Med. 1999 Feb 18;340(7):525-33. doi: 10.1056/NEJM199902183400706.
6
Disinfection, sterilization, and antisepsis: Principles, practices, current issues, new research, and new technologies.消毒、灭菌与防腐：原理、实践、当前问题、新研究与新技术。
Am J Infect Control. 2019 Jun;47S:A1-A2. doi: 10.1016/j.ajic.2019.03.035.
7
Pathogen inactivation in cellular blood components: clinical trials and implications of introduction to transfusion medicine.细胞血液成分中的病原体灭活：临床试验及引入输血医学的意义
Vox Sang. 2002 Aug;83 Suppl 1:271-5. doi: 10.1111/j.1423-0410.2002.tb05316.x.
8
Transfusion-transmitted bacterial infection: risks, sources and interventions.输血传播的细菌感染：风险、来源及干预措施
Vox Sang. 2004 Apr;86(3):157-63. doi: 10.1111/j.0042-9007.2004.00410.x.
9
[Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].[通过输血传播变异克雅氏病（vCJD）的理论风险。在许多国家，对输血血液进行白细胞和红细胞去除是一种惯例]
Lakartidningen. 2002 Mar 21;99(12):1310-4.
10
[The risk of disease transmission via blood and blood products is always there. It is important for prevention to be a step ahead].通过血液和血液制品传播疾病的风险一直存在。预防先行至关重要。
Lakartidningen. 1999 Jan 27;96(4):294-6.

引用本文的文献

1
Platelet Transfusion for Patients with Cancer: An Update.癌症患者的血小板输注：最新进展
Transfus Med Hemother. 2025 Jun 12. doi: 10.1159/000546566.
2
Rapid Sterilization of Clinical Apheresis Blood Products Using Ultra-High Dose Rate Radiation.使用超高剂量率辐射对临床单采血液制品进行快速灭菌
Int J Mol Sci. 2025 Mar 7;26(6):2424. doi: 10.3390/ijms26062424.
3
Advancements in Immunology and Microbiology Research: A Comprehensive Exploration of Key Areas.免疫学与微生物学研究进展：关键领域的全面探索
Microorganisms. 2024 Aug 14;12(8):1672. doi: 10.3390/microorganisms12081672.
4
Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction.血小板浓缩血液制品细菌安全性方法的评估：细菌筛查与病原体灭活
Front Med (Lausanne). 2024 Apr 5;11:1325602. doi: 10.3389/fmed.2024.1325602. eCollection 2024.
5
Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies.血小板启发式静脉内纳米医学用于损伤靶向性直接递血栓酶以增强凝血异常中的止血作用。
ACS Nano. 2022 Oct 25;16(10):16292-16313. doi: 10.1021/acsnano.2c05306. Epub 2022 Aug 2.
6
Assessing quality of blood components derived from whole blood treated with riboflavin and ultraviolet light and separated with a fully automated device.评估用核黄素和紫外线处理并通过全自动设备分离的全血制备的血液成分的质量。
Blood Transfus. 2022 Sep;20(5):395-403. doi: 10.2450/2022.0278-21. Epub 2022 Feb 1.
7
The Effects of Gamma Irradiation on Chemical Biomarker Recovery from Mixed Chemical/Biological Threat Exposure Specimens.伽马射线辐射对混合化学/生物威胁暴露标本中化学生物标志物回收的影响。
J Appl Lab Med. 2020 Mar 1;5(2):273-280. doi: 10.1093/jalm/jfz022.
8
Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion.撒哈拉以南非洲地区的全血病原体灭活技术与血液安全：一项包含区域讨论的系统评价
Afr J Lab Med. 2016 Jun 9;5(1):363. doi: 10.4102/ajlm.v5i1.363. eCollection 2016.
9
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.氨甲喋呤/紫外线 A 病原体灭活技术可降低血小板的活性，诱导细胞凋亡，并加速清除。
Haematologica. 2017 Oct;102(10):1650-1660. doi: 10.3324/haematol.2017.164137. Epub 2017 Jul 20.
10
Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.氧化还原蛋白质组学与血小板活化：通过了解氧化还原蛋白质组来提高输血用血小板质量
Int J Mol Sci. 2017 Feb 11;18(2):387. doi: 10.3390/ijms18020387.

本文引用的文献

1
Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.两种病原体减少技术——亚甲蓝联合光照和短波紫外线——可有效使血液制品中的丙型肝炎病毒失活。
Transfusion. 2013 May;53(5):1010-8. doi: 10.1111/j.1537-2995.2012.03858.x. Epub 2012 Aug 21.
2
Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.用于病原体灭活的THERAFLEX MB-血浆系统的主要特性
Transfus Med Hemother. 2011;38(1):55-64. doi: 10.1159/000323786. Epub 2011 Jan 27.
3
UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma.紫外线C照射用于降低血小板浓缩物和血浆中的病原体
Transfus Med Hemother. 2011;38(1):43-54. doi: 10.1159/000323845. Epub 2011 Jan 22.
4
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.用于浓缩红细胞的S-303病原体灭活技术的研发。
Transfus Med Hemother. 2011;38(1):33-42. doi: 10.1159/000324458. Epub 2011 Jan 31.
5
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™.使用INTERCEPT血液系统™对用于输血的血小板和血浆血液成分进行病原体灭活。
Transfus Med Hemother. 2011;38(1):19-31. doi: 10.1159/000323937. Epub 2011 Jan 27.
6
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.使用核黄素和紫外线光对血小板、血浆和全血进行病原体灭活技术处理
Transfus Med Hemother. 2011;38(1):8-18. doi: 10.1159/000324160. Epub 2011 Jan 31.
7
Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.经第二代 S-303 病原体灭活处理后，储存的红细胞活力得以维持。
Transfusion. 2011 Nov;51(11):2367-76. doi: 10.1111/j.1537-2995.2011.03163.x. Epub 2011 May 13.
8
[Seventeen years of haemovigilance in France: assessment and outlook].[法国十七年的血液警戒：评估与展望]
Transfus Clin Biol. 2011 Apr;18(2):140-50. doi: 10.1016/j.tracli.2011.02.024. Epub 2011 Apr 6.
9
Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation.与γ射线辐照相比，血小板制品经病原体减少处理技术处理后对人白细胞的灭活作用。
Transfusion. 2011 Jul;51(7):1397-404. doi: 10.1111/j.1537-2995.2010.02984.x. Epub 2010 Dec 13.
10
The status of pathogen-reduced plasma.病原体灭活血浆的现状。
Transfus Apher Sci. 2010 Dec;43(3):393-399. doi: 10.1016/j.transci.2010.09.006. Epub 2010 Oct 6.